Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for postoperative neurocognitive function in elderly colorectal surgery patients
ChiCTR2200061206Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in postoperative delirium (POD), postoperative pain, sleep disorder and 1 more (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Incidence of postoperative delirium at 7 days. Started Jun 2022; status: recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)postoperative painsleep disordercomplications of surgical procedures
Beyond the preview
Go deeper on ChiCTR2200061206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061206.